Medical Device Contract Manufacturing Market Top Growing Segments and Future Development
According to research report the medical device contract manufacturing market
is projected to reach USD 91.3 billion in 2024 from an estimated USD
55.0 billion by 2024, at a CAGR of 10.6% during the forecast period.
Market
growth is largely driven by the rising global disease prevalence, life
expectancy, and geriatric population. Technological advancements have
prompted end users to overhaul or update their manufacturing systems. As
this is a costly process, they look to contract manufacturing.
Ask For PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851
Based on device type,
the market is broadly segmented into IVD devices, diagnostic imaging
devices, cardiovascular devices, drug delivery devices, orthopedic
devices, respiratory care devices, ophthalmology devices, surgical
devices, diabetes care devices, dental devices, endoscopy devices,
gynecology/urology devices, personal care devices, neurology devices,
and other devices. In 2020, IVD devices accounted for the largest share
of the market. The large share of this segment can be attributed to the
increasing volume of IVD tests performed globally, the COVID-19
pandemic, the increasing availability of IVD kits and reagents, the
growing number of hospitals & clinical laboratories in developing
countries, automation & technological advancements in instruments
with high-throughput capabilities, and advances in life sciences
research.
Based on the class of device, the
market is segmented into Class I, Class II, and Class III medical
devices. In 2020, the Class II medical devices segment is projected to
grow at the highest CAGR in the market. The growth of this segment can
be attributed to the large number of medical devices that fall under
this device class and their greater utilization (compared to other
classes) by end users and caregivers in the healthcare industry. In
addition, due to the outbreak of COVID-19, governments minimized the
regulatory compliance on these devices and issued Emergency Use
Authorizations (EUA) for diagnostics and PPE kits, thereby boosting the
market growth.
Based on service, the medical
device contract manufacturing market is segmented into device
development and manufacturing services, quality management services,
packaging and assembly services and other services. The device
development and manufacturing services segment dominated this market.
The increasing adoption of contract manufacturing services in the
medical device industry, growth in the medical devices market
(especially in the single-use disposable medical devices market), and
improving device development and manufacturing capabilities are the
major factors responsible for the large share of this segment.
Some of the other leading players competing in the healthcare contract manufacturing market
are Sanmina Corporation (US), Integer Holdings Corporation (US),
Celestica Inc. (Canada), Plexus Corporation (US), Benchmark Electronics,
Inc. (US), Gerresheimer AG (Germany), West Pharmaceutical Services,
Inc. (US), Nortech Systems, Inc. (US), TE Connectivity, LTD.
(Switzerland), Consort Medical PLC (UK), Nipro Corporation (Japan),
Kimball Electronics Inc. (US), and Teleflex Incorporated (US).
The
medical device contract manufacturing market is highly fragmented with
the top 15 companies accounting for approximately 25% of the total
market. As of 2018, Flex, Ltd. (Singapore) and Jabil, Inc. (US) together
accounted for approximately 10% of the global healthcare contract
manufacturing market.
Jabil Inc. (US) was the leader in the
medical device contract manufacturing market in 2018. The company offers
a focused range of products such as diagnostic devices, diabetes care
devices, ophthalmology devices, pharmaceutical drug delivery devices,
and consumables for medical devices and services such as additive
manufacturing, contract manufacturing, quality management services, and
final goods assembly services. It also offers advanced manufacturing
technologies such as electronic manufacturing services and automation in
a number of manufacturing facilities worldwide such as Singapore,
Mexico, China, and the US, among others.
Request free report sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170622851
Asia
Pacific is expected to witness the highest CAGR during the forecast
period, owing to factors such as the increasing demand for medical
devices in this region due to the improving healthcare infrastructure,
adoption of technologically advanced products, low cost of
manufacturing, and the less stringent regulatory scenario for
manufacturing of medical devices which promotes higher usage of medical
devices as compared to most developed countries.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment